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Abstract
Background Aspects of sexual health, which can be adversely affected by chronic disease, have been inadequately explored 
in inflammatory bowel disease (IBD).
Aims We evaluated patient-reported interest in sexual activity and satisfaction with sex life in a large cohort of IBD patients. 
Methods We conducted a cross-sectional study within the Crohn’s and Colitis Foundation Partners Internet cohort. Sequential 
participants completed a 6-question supplemental online survey to examine sexual interest and satisfaction using the Patient-
Reported Outcome Measurement Information  System®  (PROMIS®) Sexual Function and Satisfaction measures. One-sample 
t tests were used to compare interest and satisfaction scores to general population norms.
Results Among 2569 individuals, 1639 had Crohn’s disease (CD), 930 had ulcerative colitis (UC) or indeterminate colitis, 
and 71% were women. Mean PROMIS scores for sexual interest were comparable to the general US population in men 
(CD: 49 and UC: 48 vs. population mean 50) and women (CD: 41 and UC: 40 vs. population mean 42). However, sexual 
satisfaction scores were lower than the US population in men (CD: 48 and UC: 48 vs. 51) and women (CD: 47 and UC: 46 
vs. 49), p < 0.01 for both. Older age, disease activity, depression, anxiety, and pain were associated with lower interest and 
satisfaction and lowered IBD-specific quality of life.
Conclusions IBD patients in a large online survey had similar levels of sexual interest but decreased sexual satisfaction 
compared to the general population. Exploring these sexual health domains during clinical encounters can aid in improving 
IBD quality of life.
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Introduction
Patients with inflammatory bowel disease (IBD), including 
Crohn’s disease (CD) and ulcerative colitis (UC), can have 
impaired quality of life as a result of depression [1], anxi-
ety [2], and fatigue [3, 4]. Sexual interest and satisfaction 
are other important aspects affecting quality of life, but it 
is unclear how these domains are impacted by IBD. Exist-
ing reports have been mixed, with some studies showing 
no differences in sexual activity [5] or frequency of sexual 
intercourse [6] between IBD patients and controls.
Conversely, one of the earliest studies reported that nearly 
a quarter of female CD patients completely abstained from 
sexual activities primarily due to abdominal pain, diarrhea, 
and fear of fecal incontience [7]. Other studies [8–10] have 
also shown that sexual dysfunction is reported in approxi-
mately 50% of women with IBD. In both men and women, 
depression appears to be a major driver of impaired sexual 
activity [5, 11, 12].
While these studies quantified differences in sexual func-
tion broadly and identified some contributing factors to 
decreased function, few studies have focused on particular 
aspects of sexual health such as sexual interest and sexual 
satisfaction among IBD patients. Marin et al. showed that 
women reported worsened sexual desire and satisfaction 
compared to men after being diagnosed with IBD [10]. 
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Factors associated with lower levels of sexual satisfaction 
in women are longer duration of CD, presence of complex 
fistulae or abscesses, and impaired pelvic floor function [13]. 
Another report described higher levels of desire and satisfac-
tion among IBD patients following proctocolectomy or proc-
tectomy in male patients and ileal pouch anal anastomosis 
(IPAA) in female patients [14].
Given the limited literature on sexual health in IBD and 
the importance of understanding this domain to improve the 
overall psychosocial well-being of IBD patients, we aimed 
to evaluate interest in sexual activity and satisfaction with 
sex life among participants in the Crohn’s and Colitis Foun-
dation Partners Internet cohort using the Patient-Reported 
Outcomes Measurement Information  System®  (PROMIS®) 
Sexual Function and Satisfaction (SexFS) measures [15–18], 
which have undergone rigorous development and validation 
based on qualitative research and psychometric evaluation 
in a large US sample [19–21]. We hypothesized that among 
IBD patients, female sex, depression, current ostomy, prior 
IPAA, perianal disease, and active steroid use would be 
associated with lower interest in sexual activity and satis-
faction with sex life.
Methods
Study Population
Crohn’s and Colitis Foundation Partners is a longitudinal 
Internet-based cohort of patients with IBD. The develop-
ment of the cohort has been described in detail previously 
[22]. Participants older than 18 years with a self-reported 
diagnosis of UC, CD, or indeterminate colitis (IC) were 
recruited through the Crohn’s and Colitis Foundation e-mail 
rosters, the Crohn’s and Colitis Foundation website, social 
media outlets, and at educational and fundraising events. All 
participants completed a baseline survey including demo-
graphic information and questions about their IBD history, 
symptoms, and medication use. Follow-up questionnaires 
every 6 months tracked changes in disease treatments, symp-
toms, and other patient-reported outcomes (PROs). A prior 
validation study demonstrated 97% accuracy of self-reported 
diagnoses of CD or UC in the cohort [23].
For this study, consecutive survey respondents between 
February and June of 2012 were invited to complete an 
optional 6 question supplemental survey in addition to their 
baseline or regularly scheduled follow-up survey (Sup-
plementary Table). The items measured interest in sexual 
activity, satisfaction with sex life, and when applicable, the 
impact of having an ostomy or IBD symptoms on satisfac-
tion with sex life. The study protocol was reviewed and 
approved by the Institutional Review Board of the University 
of North Carolina.
PROMIS SexFS Assessments
The interest in sexual activity and satisfaction with sex life 
scales were developed and validated as part of the NIH 
PROMIS initiative. The PROMIS Sexual Function and 
Satisfaction item bank has undergone rigorous develop-
ment and validation based on qualitative research and item 
response theory similar to all PROMIS measures [15–17, 
24, 25]. It was designed to be used in diverse populations, 
both with and without chronic disease. As such, the SexFS 
items are not disease-specific, though items are available 
that ask about disease- and symptom-specific effects on 
satisfaction. All items ask about sexual function and sat-
isfaction in the past 30 days. For measuring interest and 
satisfaction in a sample of both men and women, PROMIS 
offers advantages over other measures in that it uses the 
same scales and scoring for both men and women. Items 
were scored according to the strategy of SexFS measure 
(version 2.0).
Higher scores on the SexFS indicate more of the domain 
being measured. Hence, higher scores for the domains of 
interest in sexual activity and satisfaction with sex Life 
imply higher interest and greater satisfaction. Scores are 
expressed as t-scores, where the mean ± SD for the gen-
eral US sexually active adult population is 50 ± 10. US 
population norms for SexFS measures differ by sex [17], 
based on a nationally representative sample weighted to 
the 2012 Current Population Survey of 1758 men and 1757 
women, with mean age 47 (SD 17). The mean ± SD for 
sexual interest is 50 ± 10 for males and 42 ± 14 for females. 
Because of differential item functioning based on recent 
sexual activity [17], the sexual satisfaction measure is only 
scored in persons who were sexually active in the past 
30 days. Sex-specific population means for satisfaction 
are 51 ± 9 and 49 ± 11 for males and females, respectively. 
We considered a difference in score of 2–4 as a clinically 
meaningful difference similar to other PROMIS measures 
[26–28].
Other Self‑Report Assessments
The Short IBD Questionnaire (SIBDQ) was administered 
as a disease-specific measure of HRQOL [29]. Disease 
activity was evaluated using validated measures such as 
the short Crohn’s Disease Activity Index (sCDAI) for 
CD [30] and the Simple Clinical Colitis Activity Index 
(SCCAI) for UC and IC. A sCDAI < 150 is categorized 
as clinical remission for CD, and an SCCAI ≤ 2 is catego-
rized as clinical remission for UC and active disease as 
values above this threshold [30, 31]. Surveys also included 
PROMIS items from the depression, anxiety, fatigue, sleep 
disturbance, and pain interference item banks. These 
PROMIS domains are expressed as t-scores where the 
mean ± SD for the general US adult population is 50 ± 10. 
We also measured patient demographics, IBD medica-
tion use such as oral 5-aminosalicylates, prednisone, 
immunomodulators, and biologic therapies (infliximab, 
adalimumab, certolizumab pegol, golimumab, and natali-
zumab), perianal disease and pouch and ostomy status by 
self-report.
Statistical Analysis
For each domain, one-sample t tests were used to compare 
means of interest and satisfaction scores to the correspond-
ing general sex-specific population means within groups of 
UC and CD patients. Chi-square tests and ANOVA F-sta-
tistics were used to assess the relationship between interest 
and satisfaction t-scores and patient demographics, disease 
activity, quartiles of SIBDQ scores, current corticosteroid 
use, and categorical disease characteristics (current ostomy, 
prior IPAA, perianal disease).
In addition, mean PROMIS scores for interest and satis-
faction were compared across quartiles (as these scores were 
not normally distributed) of disease activity, SIBDQ scores, 
and other PROMIS measures (depression, anxiety, fatigue, 
sleep, pain) using a nonparametric test of trend for the ranks 
across ordered groups. Comparator variables such as dis-
ease activity, steroid use, ostomy/IPAA, and active perianal 
disease were dichotomized, and mean interest and satisfac-
tion scores were compared between the two groups for each 
variable using Student’s t tests. Analyses were stratified by 
sex and disease type (UC/IC or CD). Finally, a multivariable 
analysis was performed for sexual interest and satisfaction 
scores in UC and CD patients adjusted for sex, age, race, 
ethnicity, education, disease activity scores, and PROMIS 
measures for (depression, anxiety, fatigue, sleep). Statistical 
analyses were performed using SAS version 9.4.
Results
Study Population
Of 3811 individuals who were offered the optional online 
survey on sexual interest and satisfaction, 2581 (68%) com-
pleted the survey. This response rate was comparable to 
other surveys administered through the CCFA Partners to 
a subset of patients, with response rates ranging from 59 
to 71%. Twelve respondents whose sex was unknown were 
excluded, leaving a total 2569 individuals for analysis. In 
this sample, 1639 (64%) had CD and 930 (36%) had UC 
or IC (Table 1). The mean ± SD age of respondents was 
42 ± 14 years, and 71% were female. The majority was 
white 
(91%) and had a college or graduate degree. The mean time 
of disease duration was 13 ± 11 years. Seventy-seven percent 
of the sample was sexually active with a similar proportion 
among men (78%) and women (77%), and subjects with CD 
(76%) and UC (78%). Additional characteristics of the study 
population are provided in Table 1.
Interest in Sexual Activity and Satisfaction with Sex 
Life
The mean PROMIS score for interest in sexual activity was 
41 for CD women and 40 for UC women, comparable to 
the US general population mean of 42 (Table 2). However, 
satisfaction with sex life was lower for women with IBD 
(mean T scores of 47 for CD and 46 for UC) compared to the 
population mean of 49, p < 0.01. Similar to women, levels of 
interest in sexual activity in men with IBD were comparable 
to the general population (mean T scores for CD: 49 and UC: 
50 vs. population mean 50); however, mean sexual satisfac-
tion T scores were 3 points lower in men with IBD than the 
general population (CD and UC: 48 vs. population mean 
51, p < 0.01). Based on the established MID for PROMIS 
measures (2–4), the difference in sexual interest among men 
and women with IBD versus the general population are small 
but clinically meaningful. 
The relationships between sexual interest and satisfac-
tion scores and age, race/ethnicity, and educational status are 
shown in Tables 3 and 4. Scores for both domains decreased 
with increasing age in men and women, except for sexual 
satisfaction in CD men (non-significant trend observed) 
and UC women. No consistent differences were observed 
for race/ethnicity. Associations with educational level were 
also mixed, though most comparisons showed direct asso-
ciations between sexual interest and satisfaction and educa-
tional level.
In multivariable analysis, factors associated with lower 
sexual interest scores in UC and CD patients were female 
sex, increasing age, and fatigue (p < 0.05 for all). In addi-
tion, increasing anxiety was also found to be significantly 
associated with lower sexual interest scores in UC patients 
(p = 0.03). Factors associated with lower satisfaction scores 
in both UC and CD were female sex, increasing age, anxiety, 
and sleep disturbance (p < 0.05 for all).
Associations with Disease Severity, HRQOL, 
and Other PROs
As expected, mean PROMIS scores for interest in sexual 
activity and satisfaction with sex life were lower with 
increasing levels of disease activity, with the exception 
of UC women (Tables 5, 6). The magnitude of decreased 
interest and satisfaction with more severe disease activity 
was greater for men with a larger difference in PROMIS 
Table 1  Characteristics of the 
study population
a 6-mercaptopurine, azathioprine, or methotrexate deviation is 10. Higher scores indicate more of the 
domain being measured
b Infliximab, adalimumab, certolizumab pegol, or natalizumab
c Patient-Reported Outcome Information Measurement System items are calibrated so that the mean of the 
US general population is 50 and the standard
d Sexually active within past 30 days
Characteristics CD 
(n = 1639)
Mean (SD) or %
UC (n = 930)
Mean (SD) or %
Overall IBD 
(n = 2569)
Mean (SD) or %
Demographics
 Age, years 42 (14) 42 (14) 42 (14)
 Female sex 72 69 71
 Race/ethnicity
  White 93 88 91
  African-American 3 2 3
  Asian 0.3 3 2
  Other 4 6 5
 Hispanic 3 5 4
 Education completed
  < 12th grade 1 0.4 1
  12th grade 7 5 6
  Some college 22 18 20
  College 43 43 43
  Graduate school 28 34 31
 Current smoker 10 8 9
Disease characteristics
 Disease duration 15 (12) 11 (10) 13 (11)
 ≥ 1 hospitalizations in the past year 19 11 16
 ≥ 1 bowel surgery 52 15 39
 IPAA or Koch pouch 3 10 6
 Ostomy 9 5 7
 sCDAI or SCCAI 153 (100) 4 (3) n/a
 SIBDQ 5 (1) 5 (1) 5 (1)
Current medication use
5-aminosalicylates 34 66 46
Prednisone 9 13 10
Immunomodulatorsa 28 23 26
Biologic  therapyb 42 19 34
General  PROMISc measures
 Anxiety 54 (10) 55 (9) 55 (10)
 Depression 52 (10) 52 (10) 52 (10)
 Fatigue 57 (11) 55 (11) 56 (11)
 Sleep disturbance 52 (9) 52 (9) 52 (9)
 Satisfaction with social role 47 (10) 48 (10) 48 (10)
 Pain 54 (10) 52 (10) 53 (10)
Sexually  actived
 Yes 76 78 77
 Male 77 78 78
 Female 76 79 77
scores between the lowest quartile (Q1) and highest quar-
tile (Q4) when compared to CD women. Additionally, 
sexual interest and satisfaction scores were positively 
associated with disease-specific quality of life.
Increasing levels of depression, anxiety, fatigue, sleep 
disturbance, and pain interference were associated with 
decreased sexual interest and satisfaction, and the magni-
tude and strength of each of these associations were inde-
pendent of gender and disease type.
Additional Associations
Prednisone use and perianal disease did not greatly impact 
interest and satisfaction scores, even though CD women with 
current steroid use had a lower interest score (39 vs. 41, 
p = 0.04). Having an ostomy was also not associated with 
lower sexual interest or satisfaction. Finally, among UC 
patients, sexual interest and satisfaction scores were identi-
cal for patients with and without IPAA.
Table 2  Mean PROMIS sexual interest and satisfaction* scores in IBD patients compared to the general population stratified by sex and disease 
type
All scores are T-scores (M = 50, SD = 10)
*Satisfaction with sex life scores calculated from among those who were sexually active within past 30 days
N CD (mean, 95% CI) General popula-
tion (mean)
p value n UC (mean, 95% CI) General popula-
tion (mean)
p value
Interest in sexual activity
 Men 453 49 (48–50) 50 < 0.01 287 50 (48–51) 50 0.24
 Women 1186 41 (40–41) 42 < 0.01 643 40 (39–41) 42 < 0.01
Satisfaction with sex life
 Men 350 48 (48–49) 51 < 0.01 225 48 (47–49) 51 < 0.01
 Women 897 47 (46–47) 49 < 0.01 505 46 (45–47) 49 < 0.01
Table 3  Relationships between 
patient characteristics and 
PROMIS sexual interest and 
 satisfactiona scores in men
p values comparing differences between groups in each category
a Satisfaction with sex life scores calculated from among those who were sexually active within past 30 days
Interest in sexual activity
Mean (SD)












 18–30 52 (10) < 0.01 51 (9) < 0.01 50 (6) 0.21 49 (7) < 0.01
 30–40 49 (11) 53 (8) 47 (7) 50 (7)
 40–50 47 (11) 49 (11) 48 (8) 47 (7)
 50–60 48 (11) 48 (9) 48 (8) 46 (6)
> 60 48 (9) 44 (11) 48 (7) 46 (7)
Race/ethnicity
 White 48 (11) 0.43 49 (10) 0.41 48 (7) 0.75 47 (7) 0.26
 Black 40 (3) 38 (–) 45 (9) n/a
 Asian n/a 53 (6) n/a 52 (8)
 Other 48 (10) 52 (11) 49 (6) 50 (9)
 Hispanic 49 (8) 0.82 54 (12) 0.22 47 (8) 0.54 50 (7) 0.46
Education
 < 12th grade 60 (8) 0.16 27 (8) 0.01 38 (5) 0.22 n/a < 0.01
 12th grade 48 (11) 46 (9) 47 (7) 48 (6)
 Some college 48 (11) 49 (12) 48 (6) 47 (7)
 College 48 (11) 50 (9) 48 (7) 48 (7)
 Graduate 50 (9) 50 (10) 49 (7) 49 (6)
Discussion
Our data suggest that, while women and men with IBD 
report similar levels of interest in sexual activity compared 
to the general population, they experience significantly lower 
satisfaction with their sex lives than their counterparts in the 
US general population. Additionally, we found that sexual 
interest and satisfaction among IBD patients were directly 
associated with disease-specific quality of life. Interest in 
sexual activity and satisfaction with sex life decreased with 
older age (except in CD men), and women had lower interest 
in sexual activity compared to men. Sexual interest and sat-
isfaction were inversely associated with disease activity as 
measured by self-reported symptom-based disease activity 
indices (SCDAI and SCCAI), particularly among men. As 
anticipated, depression, anxiety, fatigue, sleep disturbance, 
and pain interference were associated with decreased inter-
est and satisfaction scores. Perianal disease and presence of 
ostomy or IPAA did not impact either interest or satisfaction.
The findings from this study add to the limited litera-
ture focusing on specific aspects of sexual health among 
IBD patients. Differentiating between the various compo-
nents of sexual health, such as interest and satisfaction, 
is important because there may not always be a positive 
correlation between them. For example, one study in IBD 
patients showed that despite an increase in vaginal dryness, 
dyspareunia, and pain after surgery that interfered with sex-
ual function, there was no significant change in sexual desire 
or satisfaction [32]. Similar incongruent findings between 
satisfaction with sex life and indicators of sexual dysfunction 
(such as erectile dysfunction) were found in cancer patients 
[15].
Our results are consistent with another study that found 
lower sexual interest for women than men, as compared to 
the general population [10]. However, the overall satisfaction 
with sex life was lower in men compared to women in our 
study. The lack of difference in both interest and satisfac-
tion between those with and without an ostomy or IPAA is 
similar to previous findings reported by Bambrick et al. [32]. 
The inverse association between interest in sexual activity 
and satisfaction with increasing disease activity was also 
observed in a study that focused on sexual function in Ger-
man IBD patients [11]. Men in that study reported higher 
levels of erectile dysfunction with increasing disease activ-
ity; however, disease activity did not affect sexual function 
in women.
The association between concurrent anxiety and depres-
sive symptoms and lower sexual interest and satisfaction is 
also consistent with emerging literature. Anxiety and depres-
sion are common in patients with IBD [33], and decreased 
interest in sex is a common symptom in patients with depres-
sion [34]. Our study as well as three surveys by Timmer 
 
Table 4  Relationships between 
patient characteristics and 
PROMIS sexual interest and 
 satisfactiona scores in women
p values comparing differences between groups in each category
a Satisfaction with sex life scores calculated from among those who were sexually active within past 30 days
Interest in sexual activity
Mean (SD)












 18–30 44 (11) < 0.01 42 (11) < 0.01 48 (8) 0.04 46 (8) 0.72
 30–40 41 (11) 41 (10) 48 (8) 47 (6)
 40–50 39 (11) 39 (11) 46 (8) 46 (8)
 50–60 38 (11) 37 (11) 46 (8) 45 (8)
> 60 37 (10) 37 (9) 46 (8) 46 (8)
Race/ethnicity
 White 41 (11) 0.22 40 (11) 0.04 47 (8) 0.58 47 (8) 0.67
 Black 41 (12) 49 (10) 45 (7) 46 (4)
 Asian 57 (4) 35 (11) 51 (5) 43 (5)
 Other 39 (13) 37 (12) 50 (6) 45 (8)
 Hispanic 38 (10) 0.29 42 (11) 0.32 47 (8) 0.96 48 (6) 0.11
Education
 < 12th grade 41 (10) 0.71 35 (12) 0.02 47 (8) 0.23 44 (–) 0.01
 12th grade 42 (11) 35 (11) 48 (9) 42 (6)
 Some college 41 (12) 39 (11) 46 (8) 45 (8)
 College 41 (11) 41 (11) 47 (8) 47 (8)
 Graduate 40 (11) 40 (10) 47 (8) 46 (7)
Table 5  Relationships of 
sexual interest and  satisfactiona 
and quality of life, patient 
outcome measures and disease 
characteristics in men
p values comparing differences between groups in each category
a Satisfaction with sex life scores calculated from among those who were sexually active within past 30 days
b SIBDQ scores range from 10 to 70
Interest in sexual activity
Mean (SD)












 Q1 52 (10) < 0.01 51 (9) 0.02 50 (7) < 0.01 50 (6) 0.01
 Q2 50 (10) 50 (10) 49 (7) 48 (8)
 Q3 47 (11) 48 (9) 48 (7) 47 (6)
 Q4 45 (10) 46 (11) 44 (6) 46 (8)
SIBDQb
 Q1 51 (11) < 0.01 52 (9) < 0.01 51 (6) < 0.01 50 (7) < 0.01
 Q2 50 (10) 49 (9) 49 (7) 47 (5)
 Q3 48 (10) 48 (10) 47 (7) 47 (8)
 Q4 45 (11) 46 (12) 45 (6) 44 (7)
Depression
 Q1 51 (10) < 0.01 51 (9) < 0.01 50 (7) < 0.01 49 (7) < 0.01
 Q2 49 (10) 50 (9) 49 (7) 49 (6)
 Q3 49 (10) 49 (11) 47 (7) 47 (5)
 Q4 45 (11) 45 (11) 45 (6) 44 (7)
Anxiety
 Q1 51 (11) < 0.01 50 (9) < 0.01 50 (7) < 0.01 48 (7) < 0.01
 Q2 49 (10) 53 (9) 48 (7) 50 (6)
 Q3 46 (10) 47 (11) 45 (7) 49 (6)
 Q4 45 (11) 46 (11) 46 (6) 43 (6)
Fatigue
 Q1 51 (10) < 0.01 51 (9) < 0.01 50 (7) < 0.01 49 (6) < 0.01
 Q2 50 (11) 49 (9) 49 (7) 47 (6)
 Q3 47 (10) 48 (11) 47 (7) 47 (8)
 Q4 43 (10) 41 (12) 44 (6) 40 (6)
Sleep
 Q1 51 (11) 0.04 49 (10) 0.25 50 (7) < 0.01 50 (7) < 0.01
 Q2 49 (10) 51 (10) 49 (7) 48 (6)
 Q3 48 (11) 49 (10) 46 (7) 46 (7)
 Q4 46 (10) 47 (10) 46 (7) 44 (7)
Pain
 Q1 50 (9) < 0.01 52 (9) 0.04 50 (7) 0.40 51 (7) < 0.01
 Q2 51 (12) 47 (8) 49 (6) 45 (7)
 Q3 45 (11) 48 (8) 47 (7) 45 (8)
 Q4 44 (10) 45 (15) 47 (7) 46 (8)
Prednisone use
 Yes 48 (10) 0.67 49 (9) 0.63 47 (8) 0.19 48 (7) 0.97
 No 49 (11) 50 (10) 48 (7) 48 (7)
Perianal disease
 Yes 48 (11) 0.66 n/a n/a 47 (6) 0.34 n/a n/a
 No 49 (11) n/a 48 (7) n/a
Current ostomy
 Yes 49 (11) 0.93 55 (7) 0.09 47 (9) 0.24 47 (9) 0.82
 No 49 (11) 49 (10) 48 (7) 48 (7)
IPAA
 Yes n/a n/a 53 (10) 0.11 n/a n/a 48 (9) 0.97
 No n/a 49 (10) n/a 48 (7)
Table 6  Relationships of 
sexual interest and  satisfactiona 
and quality of life, patient 
outcome measures and disease 
characteristics in women
p values comparing differences between groups in each category
a Satisfaction with sex life scores calculated from among those who were sexually active within past 30 days
b SIBDQ scores range from 10 to 70
Interest in sexual activity
Mean (SD)














 Q1 43 (11) < 0.01 41 (10) 0.11 48 (8) < 0.01 47 (7) 0.10
 Q2 41 (11) 39 (10) 47 (8) 46 (7)
 Q3 40 (11) 40 (11) 47 (8) 46 (8)
 Q4 39 (12) 39 (12) 45 (8) 45 (8)
SIBDQb
 Q1 43 (11) < 0.01 42 (10) < 0.01 49 (8) < 0.01 49 (7) < 0.01
 Q2 41 (11) 41 (10) 48 (8) 47 (7)
 Q3 41 (11) 39 (11) 46 (8) 45 (8)
 Q4 39 (12) 38 (11) 44 (8) 44 (7)
Depression
 Q1 43 (11) < 0.01 41 (11) 0.01 49 (8) < 0.01 48 (8) < 0.01
 Q2 42 (11) 41 (10) 48 (8) 47 (7)
 Q3 40 (11) 40 (10) 46 (7) 45 (7)
 Q4 39 (12) 38 (12) 44 (8) 44 (8)
Anxiety
 Q1 43 (11) < 0.01 40 (10) < 0.01 49 (8) < 0.01 47 (7) < 0.01
 Q2 41 (11) 42 (10) 48 (8) 47 (8)
 Q3 40 (11) 40 (11) 46 (8) 46 (7)
 Q4 39 (12) 37 (11) 44 (8) 44 (7)
Fatigue
 Q1 43 (11) < 0.01 42 (10) < 0.01 49 (8) < 0.01 48 (8) < 0.01
 Q2 41 (11) 41 (10) 48 (8) 47 (7)
 Q3 41 (11) 38 (10) 46 (8) 44 (7)
 Q4 38 (12) 38 (12) 45 (9) 44 (7)
Sleep
 Q1 42 (11) 0.03 41 (10) < 0.01 49 (8) < 0.01 48 (7) < 0.01
 Q2 41 (11) 41 (11) 47 (8) 46 (7)
 Q3 41 (11) 39 (11) 46 (8) 45 (7)
 Q4 40 (12) 37 (11) 46 (8) 44 (7)
Pain
 Q1 43 (11) 0.04 43 (11) < 0.01 49 (8) < 0.01 48 (8) < 0.01
 Q2 41 (11) 39 (11) 48 (8) 46 (7)
 Q3 41 (11) 40 (11) 47 (8) 46 (7)
 Q4 39 (13) 36 (11) 46 (9) 43 (8)
Prednisone use
 Yes 39 (12) 0.04 40 (11) 0.96 46 (8) 0.34 47 (8) 0.38
 No 41 (11) 40 (11) 47 (8) 46 (7)
Perianal disease
 Yes 40 (12) 0.16 n/a n/a 46 (8) 0.08 n/a n/a
 No 41 (11) n/a 47 (8) n/a
Current ostomy
 Yes 42 (13) 0.47 40 (10) 0.95 48 (8) 0.14 45 (8) 0.67
 No 41 (11) 40 (11) 47 (8) 46 (8)
IPAA
 Yes n/a n/a 39 (11) 0.31 n/a n/a 46 (8) 0.97
 No n/a 40 (11) n/a 46 (8)
et al. confirmed an inverse relationship between depression 
and sexual function [5, 9, 11, 12]. It is possible that depres-
sion is more common in patients with IBD with a resultant 
decrease in interest in sexual activity and satisfaction with 
sex life. Alternatively, decreased sexual interest and satis-
faction secondary to IBD itself may result in depression. It 
seems likely that both of these theoretical models exist in 
patients with IBD.
Our study has important strengths. First, we surveyed a 
well-characterized population of patients with IBD from 
an existing registry. The study was the largest to date to 
assess interest in sexual activity and satisfaction with sex 
life in patients with IBD with more than 2500 participants. 
Although we did not do an a priori sample size determina-
tion, the large study population provided a high degree of 
statistical power and precision for our analyses. Our study 
is also the only one to our knowledge that reports on these 
specific aspects of sexual health in patients in the USA, 
except for one retrospective series of patients before and 
after IPAA. In addition, the high survey response rate (68%) 
likely reduced reporting bias, and using an electronic survey 
instead of a face-to-face survey likely decreased reticence 
among participants to answer questions about sex. Lastly, 
we used a rigorously tested and validated measure, PROMIS 
SexFS, to measure interest in sexual activity and satisfaction 
with sex life that offers a built-in comparison to US general 
population norms.
Despite the numerous strengths of the study, several limi-
tations exist. First, as we sampled a volunteer-based cohort, 
our results may not be generalizable to the IBD community 
at large in the USA. As the study was cross-sectional, we 
could not evaluate the causality of any of the associations 
between sexual interest and satisfaction an other indicator of 
disease severity or patient-reported outcomes. Longitudinal 
studies are needed to further explore the impact of clinical 
factors and medical and/or surgical treatments on subsequent 
sexual interest and satisfaction. An additional limitation is 
that the diagnosis of IBD within our cohort is by self-report. 
Therefore, it is possible that misclassification exists. How-
ever, in a validation study including a random sample from 
CCFA Partners, > 97% had their IBD diagnosis confirmed 
by medical records [23]. Similarly, although we assessed 
disease activity through self-reported, symptom-based 
indices, it was not practical to perform endoscopic assess-
ment. Finally, other variables relevant to sexual health such 
as number of sex partners and information on body image 
were not collected in this study and should be included in 
future investigations.
Our findings raise awareness of the scope of the problem 
of sexual health among IBD patients in the USA and identify 
a health issue that many patients may be embarrassed to 
discuss with their provider. Accordingly, providers should 
consider querying patients about how their IBD might be 
affecting their sex life. Such conversations could be facili-
tated by the administration of measures such as the PROMIS 
SexFS. If problems pertaining to sexual interest and satisfac-
tion are identified by clinicians, targeted treatment of active 
disease, management of concurrent psychiatric disease, and 
selected referral to providers specializing in sexual disorders 
may improve these important health domains and lead to an 
improved overall quality of life.
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